| 000 | 01383cam a22003615i 4500 | ||
|---|---|---|---|
| 005 | 20250919085750.0 | ||
| 008 | 161208s2014 nyua bi 000 0 eng | ||
| 020 |
_a9781634630573 (hardcover) _cRM794.20 |
||
| 039 | 9 |
_a201612291042 _bfadza _y12-08-2016 _zruzini |
|
| 040 |
_aDLC _beng _erda _cDLC _dUKM |
||
| 090 | _aQV150.S797 2015 9 | ||
| 090 |
_aQV150 _b.S797 2015 9 |
||
| 245 | 0 | 0 |
_aStatins : _bmedical uses, mechanisms of action and clinical outcomes / _ceditor Eric R. Travers. |
| 264 | 1 |
_aHauppauge, NY : _bNova Science Publishers, _c2015. |
|
| 264 | 4 | _c©2015. | |
| 300 |
_a222 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aPharmacology - research, safety testing and regulation | |
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 |
_aCardiovascular agents _xPharmacology. |
|
| 700 | 1 |
_aTravers, Eric R., _eeditor. |
|
| 830 | 0 | _aPharmacology - research, safety testing and regulation | |
| 907 |
_a.b16395360 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV150.S797 2015 9 |
||
| 914 | _avtls003613630 | ||
| 990 | _amfh | ||
| 991 | _aProgram Sains Bioperubatan, KKL | ||
| 998 |
_ad _b2016-08-12 _cm _da _feng _gnyu _y0 _z.b16395360 |
||
| 999 |
_c612927 _d612927 |
||